The Signifi cance of Mycobacterium abscessus Subsp ecies abscessus Isolation during Mycobacterium avium Complex Lung Disease Therapy

Chest

Volumn 147, Issue 5, 2015, Pages 1369-1375

  Griffith, David E ^a   Philley, Julie V ^a   Brown Elliott, Barbara A ^a   Benwill, Jeana L ^a   Shepherd, Sara ^a   York, Deanna ^a   Wallace, Richard J ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; ETHAMBUTOL; LINEZOLID; MACROLIDE; RIFAMPICIN; TIGECYCLINE;

AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE; PRIORITY JOURNAL; SPUTUM CULTURE; ATYPICAL MYCOBACTERIUM; CASE REPORT; CLASSIFICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;

AGED; FEMALE; HUMANS; MALE; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NONTUBERCULOUS MYCOBACTERIA;

EID: 84929497999     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1297     Document Type: Article

References (20)

1. Griffith DE , Girard WM , Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis. 1993 147 5, 1271-1278.
2. Griffi th DE, Aksamit T, Brown-Elliott BA, et al ; ATS Mycobacterial Diseases Subcommittee ; American Th oracic Society ; Infectious Disease Society of America. An offi cial ATS/IDSA statement: d iagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 ; 175 (4): 367-416.
3. Jarand J , Levin A , Zhang L , Huitt G , Mitchell JD , Da ley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis. 2011 ; 52 (5): 565-571.
4. Jeon K , Kwon OJ , Lee NY , et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med. 2009 ; 180 (9): 896-902.
5. Epstein MD , Aranda CP , Bonk S , Hanna B , Rom WN. The signifi cance of Mycobacterium avium complex cultivation in the sputum of patients with pulmonary tuberculosis. Chest. 1997 ; 111 (1): 142-147.
6. Jun HJ , Jeon K , Um SW , Kwon OJ , Lee NY , Koh WJ. Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis. Respir Med. 2009 ; 103 (12): 1936-1940.
7. Huang CT , Tsai YJ , Shu CC , et al ; Tami Group. Clinical signifi cance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients. Respir Med. 2009 ; 103 (10): 1484-1491.
8. Kendall BA , Varley CD , Hedberg K , Cassidy PM , Winthrop KL. Isolation of non-tuberculous mycobacteria from the sputum of patients with active tuberculosis. Int J Tuberc Lung Dis. 2010 ; 14 (5): 654-656.
9. Hwang SM , Lim MS , Hong YJ , et al. Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens. Tuberculosis (Edinb). 2013 ; 93 (6): 642-646.
10. Damaraju D , Jamieson F , Chedore P , Marras TK. Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada. Int J Tuberc Lung Dis. 2013 ; 17 (5): 676-681.
11. Wallace RJ Jr. , Brown-Elliott BA , McNulty S , et al. Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. C hest. 2014 ; 146 (2): 27 6-282.
12. Wallace RJ Jr. , Glassroth J , Griffi th DE , Olivier KN , Cook JL , Gordin F. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Th is offi cial statement of the American Thoracic Society wa s approved by the Board of Directors, March 1997. Am J Respir Crit Care Med. 1997 ; 156 (2 pt 2): S1-S25.
13. Wallace RJ Jr., Brown BA, Griffi th DE, et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med. 1994 ; 149 (5): 1335-1341.
14. Wallace RJ Jr. , Brown BA , Griffi th DE , Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med. 1996 ; 153 (6 pt 1): 1766-1772.
15. Telenti A , Marchesi F , Balz M , Bally F , Böttger EC , Bodmer T. Rapid identifi cation of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993 ; 31 (2): 175-178.
16. Harada T , Akiyama Y , Kurashima A , et al. Clinical and microbiological diff erences between Mycobacterium abscessus and Mycobacterium massilien se lung diseases. J Clin Microbiol. 2012 ; 50 (11): 3556-3561.
17. Koh WJ , Jeon K , Lee NY , et al. Clinical signifi cance of diff erentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med. 2011; 183(3): 405-410.
18. Wong YL, Ong CS, Ngeow YF. Molecular typing of Mycobacterium abscessus based on tandem-repeat polymorphism. J Clin Microbiol. 2012 ; 50 (9): 3084-3088.
19. Shin SJ, Choi GE, Cho SN, et al. Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis. 2013; 57(1): 32-39.
20. Cheng A , Liu YC , Chen ML , et al. Extrapulmonary infections caused by a dominant strain of Mycobac terium mas siliense (Mycobacterium abscessus subspecies bolletii). Clin Microbiol Infect. 2013 ; 19 (10): E473-E482.